Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.70    -0.115 (-2.39%)
Bid:
4.70
Ask:
4.76
Spread: 0.06 (1.277%)
Market Cap: £225.58m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Directorate Change

8 Jun 2011 07:00

RNS Number : 0183I
Seeing Machines Limited
08 June 2011
 



8 June 2011

SEEING MACHINES (the "Company")

 

CEO TO DEPART AT END OF CONTRACT

Seeing Machines Limited (AIM:SEE), a leading developer of advanced vision based industrial systems, announces today that CEO and Director Dr Nick Cerneaz will leave the Company in July 2011.

Dr Cerneaz has been with the Company since 2005 and took over as CEO in September 2005 and led the Company at the time of its listing on AIM in December 2005. For the six years that he has been with the company he has commuted to the Canberra head office from his home in Sydney where he lives with his wife and young family. Dr Cerneaz and the Board of Seeing Machines have agreed his tenure as CEO will conclude at the end of this contract. Dr Cerneaz has also agreed to assist the Company in a consulting capacity throughout a handover period as required.

The Board is currently conducting a search for a replacement to lead the Company, as it seeks to move through the next phase of growth and commercialisation. Seeing Machines manufactures a range of world leading products from fatigue management tools through to 3D visualisation and medical technologies, and the Board remains committed to driving a strategy of growth through commercialisation of these technologies and products.

Dr Cerneaz commented: "I have very much enjoyed the efforts and contribution I have made at Seeing Machines and greatly valued the opportunity to work with such a dedicated, professional and energetic team. We have successfully moved the Company through an extensive period of development and laid the foundations for tremendous commercial success ahead, particularly with significant contracts established in our DSS and faceAPI businesses and strong pipelines ahead. I wish to take this opportunity to thank all my colleagues and the stakeholders in the business that have encouraged and supported our efforts and wish the company well in its forward endeavours."

Chairman Bill Mobbs commenting on Dr Cerneaz's departure said: "The Board is extremely grateful to Nick for his leadership of the Company throughout his tenure which was characterised by strong commitment, professionalism, drive and enthusiasm in taking the Company forward. We wish Nick well in his future endeavours and join with everyone at Seeing Machines in thanking Nick wholeheartedly for his efforts on behalf of the Company. "

Enquiries:

Seeing Machines Limited

Bill Mobbs, Chairman

+61 (0) 2 6103 4700

Daniel Stewart & Company plc

Oliver Rigby

+44 (0) 20 7776 6550

Walbrook PR Ltd

 

Paul McManus

 

Paul Cornelius

+44 (0) 20 7933 8780+44 (0) 7980 541 893, paul.mcmanus@walbrookpr.com

+44 (0) 7866 384 707, paul.cornelius@walbrookir.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGMGGVDNRGMZM
Date   Source Headline
15th Jun 201810:43 amRNSKey Staff Recognised
7th Jun 201811:05 amRNSSecond Price Monitoring Extn
7th Jun 201811:00 amRNSPrice Monitoring Extension
5th Jun 201811:05 amRNSSecond Price Monitoring Extn
5th Jun 201811:00 amRNSPrice Monitoring Extension
4th Jun 20187:00 amRNSAutomotive design win with US OEM for FOVIO chip
21st May 20187:00 amRNSBusiness Outlook Update
18th May 201810:14 amRNSEuropean Commission Agenda Affirms SEE Tech
17th May 20184:40 pmRNSSecond Price Monitoring Extn
17th May 20184:35 pmRNSPrice Monitoring Extension
16th May 20187:00 amRNSAustralian Distributor Expands Guardian Commitment
9th May 20184:40 pmRNSSecond Price Monitoring Extn
9th May 20184:35 pmRNSPrice Monitoring Extension
26th Apr 20187:08 amRNSAutomotive Design Award with Premium German OEM
12th Apr 20187:00 amRNSChange of Adviser
12th Mar 20187:00 amRNSHalf Year Results to 31 December 2017
9th Mar 20187:52 amRNSStatement regarding Press Speculation
28th Feb 20187:00 amRNSNotice of Results & Investor Events
22nd Feb 20188:13 amRNSHolding(s) in Company
22nd Feb 20188:00 amRNSBlock Listing Cancellation
21st Feb 20189:00 amRNSDirectorate Change Update
8th Feb 20187:00 amRNSTrading Update & Fleet, Rail and Off-Road Update
29th Jan 20187:00 amRNSDirectorate Change
23rd Jan 201810:54 amRNSHolding(s) in Company
16th Jan 20189:22 amRNSResult of Offer and Total Voting Rights
9th Jan 201810:44 amRNSHolding(s) in Company
8th Jan 20189:23 amRNSHolding(s) in Company
3rd Jan 20188:44 amRNSResult of General Meeting and Total Voting Rights
22nd Dec 20177:00 amRNSBlock Listing Return and Total Voting Rights
5th Dec 20173:57 pmRNSSuccessful Placing and Subscriptions to raise £35m
4th Dec 20175:33 pmRNSProposed Accelerated Bookbuild
30th Nov 20177:00 amRNSDubai Distributor Wins Guardian Contracts in 2017
17th Nov 20177:01 amRNSResult of AGM
17th Nov 20177:00 amRNSAGM Statement
2nd Nov 201710:02 amRNSIssue of Shares to Directors and Staff & TVR
30th Oct 20177:00 amRNSNew DMS Program Award
25th Oct 20179:00 amRNSHolding(s) in Company
25th Oct 20177:00 amRNSEmirates and Seeing Machines Collaboration
24th Oct 20177:00 amRNSEuro NCAP and NTSB - Driver Monitoring Systems
23rd Oct 20177:00 amRNSNotice of AGM
17th Oct 201712:40 pmRNSBusiness Outlook Update
10th Oct 20179:56 amRNSHolding(s) in Company
10th Oct 20177:00 amRNSGM 2018 Cadillac CT6 Super Cruise System
11th Sep 20177:00 amRNSFinal Results
8th Sep 201712:10 pmRNSNotice of Results
8th Sep 20177:00 amRNSGlobal Agreement with Progress Rail
23rd Aug 201710:37 amRNSHolding(s) in Company
17th Aug 20177:00 amRNSAutoliv Driver Monitoring Systems
15th Aug 20179:36 amRNSFleet Partnership Agreement with Geotab
11th Aug 201712:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.